Formulations are not standardised concentrations vary by compounding pharmacy, which is one reason cross-clinic comparisons and published timelines are unreliable
However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)
Frequently asked questions about medical expenses related to nutrition, wellness and general health
doi: 10.1016/j.ajpath.2019.10.008 52 BaggioLLDruckerDJ
Understanding how a specific platform structures its care model and verifying that structure independently is an important part of the evaluation process for anyone considering this route
However, like many medications, semaglutide has side effects